Kenvue Inc. (NYSE:KVUE) Shares Acquired by Thomasville National Bank

Thomasville National Bank increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 6.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 696,641 shares of the company’s stock after purchasing an additional 42,504 shares during the period. Kenvue accounts for about 1.2% of Thomasville National Bank’s holdings, making the stock its 29th biggest position. Thomasville National Bank’s holdings in Kenvue were worth $16,113,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP acquired a new position in shares of Kenvue in the fourth quarter worth $41,000. Teachers Retirement System of The State of Kentucky acquired a new position in Kenvue in the 4th quarter valued at about $3,187,000. Syon Capital LLC lifted its holdings in Kenvue by 78.4% in the 4th quarter. Syon Capital LLC now owns 29,276 shares of the company’s stock valued at $630,000 after purchasing an additional 12,865 shares in the last quarter. SageView Advisory Group LLC acquired a new stake in shares of Kenvue during the 4th quarter worth about $262,000. Finally, Vanguard Group Inc. grew its holdings in shares of Kenvue by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 148,880,588 shares of the company’s stock worth $3,205,399,000 after buying an additional 2,226,390 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Up 0.7 %

Shares of NYSE:KVUE opened at $21.46 on Monday. The stock has a 50-day simple moving average of $22.13 and a 200-day simple moving average of $20.18. The stock has a market capitalization of $41.09 billion, a P/E ratio of 27.51, a PEG ratio of 2.76 and a beta of 1.40. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $23.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.68 and a current ratio of 0.99.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same period in the previous year, the firm earned $0.32 earnings per share. Kenvue’s revenue for the quarter was down .3% on a year-over-year basis. Equities analysts forecast that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Shareholders of record on Wednesday, August 14th were paid a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.82%. The ex-dividend date of this dividend was Wednesday, August 14th. This is a boost from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s payout ratio is currently 105.13%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on KVUE shares. Jefferies Financial Group started coverage on shares of Kenvue in a research note on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective on the stock. JPMorgan Chase & Co. raised their price objective on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a report on Friday. UBS Group upped their target price on Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Piper Sandler raised their price target on Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, September 23rd. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Kenvue currently has an average rating of “Hold” and an average price target of $22.20.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.